Concepedia

Jay Zhi

JZ

Statistics

Publications

3

Citations

167

H-Index

3

Active since

2010

Affiliations

Athenex (United States)(Current)

Jay Zhi is an author at Athenex (United States) specializing in treatment periods, glucose challenge test, and diabetes mellitus biochemistry.

Publications per year

2010–2022

3

Publications

3

Piragliatin (RO4389620), a Novel Glucokinase Activator, Lowers Plasma Glucose Both in the Postabsorptive State and after a Glucose Challenge in Patients with Type 2 Diabetes Mellitus: A Mechanistic Study

Riccardo C. Bonadonna, Tim Heise, Christophe Arbet‐Engels et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 143 citations · Full text

, , +14

Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study

Christopher Jackson, Tak Hung, Eva Segelov et al. · British Journal of Clinical Pharmacology · 2021 · 14 citations · Full text

, , +15

A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies

Wen Wee, Jing Li, Nilofer S. Azad et al. · Cancer Chemotherapy and Pharmacology · 2022 · 10 citations

, , +13

1–3 of 3